COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
Mark S Anderson
Institution
University of California, San Francisco
Address
San Francisco
California
United States
vCard
Download vCard
Publication Timeline
COVID-19 publications
All Publications
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To see the data from both graphs as text,
click here
.
Year
Publications
2002
2
2003
1
2004
1
2005
4
2006
1
2007
3
2008
7
2009
8
2010
6
2011
3
2012
3
2013
8
2014
7
2015
8
2016
7
2017
9
2018
9
2019
2
2020
1
2021
4
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To return to the graphs,
click here
.
Publication Field Summary
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
Publication List
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Show:
All coronarirus related publications
|
Covid-19 specific publications
|
All publications
Sort By:
Newest
|
Oldest
|
Most Cited
|
Most Discussed
PMC Citations
indicate the number of times the publication was cited by articles in PubMed Central, and the
Altmetric
score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.)
Fields
are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation
tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
van der Wijst MGP
,
Vazquez SE
,
Hartoularos GC
,
Bastard P
,
Grant T
,
Bueno R
,
Lee DS
,
Greenland JR
,
Sun Y
,
Perez R
,
Ogorodnikov A
,
Ward A
,
Mann SA
,
Lynch KL
,
Yun C
,
Havlir DV
,
Chamie G
,
Marquez C
,
Greenhouse B
,
Lionakis MS
,
Norris PJ
,
Dumont LJ
,
Kelly K
,
Zhang P
,
Zhang Q
,
Gervais A
,
Le Voyer T
,
Whatley A
,
Si Y
,
Byrne A
,
Combes AJ
,
Rao AA
,
Song YS
,
Fragiadakis GK
,
Kangelaris K
,
Calfee CS
,
Erle DJ
,
Hendrickson C
,
Krummel MF
,
Woodruff PG
,
Langelier CR
,
Casanova JL
,
Derisi JL
,
Anderson MS
,
Ye CJ
. Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19. Sci Transl Med. 2021 09 22; 13(612):eabh2624.
PMID:
34429372
.
Citations:
10
Fields:
Med
Medicine (General)
Sci
Science
Translation:
Humans
Bastard P
,
Gervais A
,
Le Voyer T
,
Rosain J
,
Philippot Q
,
Manry J
,
Michailidis E
,
Hoffmann HH
,
Eto S
,
Garcia-Prat M
,
Bizien L
,
Parra-Martínez A
,
Yang R
,
Haljasmägi L
,
Migaud M
,
Särekannu K
,
Maslovskaja J
,
de Prost N
,
Tandjaoui-Lambiotte Y
,
Luyt CE
,
Amador-Borrero B
,
Gaudet A
,
Poissy J
,
Morel P
,
Richard P
,
Cognasse F
,
Troya J
,
Trouillet-Assant S
,
Belot A
,
Saker K
,
Garçon P
,
Rivière JG
,
Lagier JC
,
Gentile S
,
Rosen LB
,
Shaw E
,
Morio T
,
Tanaka J
,
Dalmau D
,
Tharaux PL
, Sene D, Stepanian A, Megarbane B,
Triantafyllia V
,
Fekkar A
,
Heath JR
,
Franco JL
,
Anaya JM
,
Solé-Violán J
,
Imberti L
,
Biondi A
,
Bonfanti P
,
Castagnoli R
,
Delmonte OM
,
Zhang Y
,
Snow AL
,
Holland SM
,
Biggs C
, Moncada-Vélez M,
Arias AA
,
Lorenzo L
,
Boucherit S
,
Coulibaly B
, et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021 08 19; 6(62).
PMID:
34413139
.
Citations:
28
Fields:
All
Allergy and Immunology
Translation:
Humans
Bastard P
,
Orlova E
,
Sozaeva L
,
Lévy R
,
James A
,
Schmitt MM
,
Ochoa S
,
Kareva M
,
Rodina Y
,
Gervais A
,
Le Voyer T
,
Rosain J
,
Philippot Q
,
Neehus AL
,
Shaw E
,
Migaud M
,
Bizien L
,
Ekwall O
,
Berg S
,
Beccuti G
,
Ghizzoni L
,
Thiriez G
,
Pavot A
,
Goujard C
,
Frémond ML
,
Carter E
,
Rothenbuhler A
,
Linglart A
,
Mignot B
,
Comte A
,
Cheikh N
,
Hermine O
,
Breivik L
,
Husebye ES
,
Humbert S
,
Rohrlich P
,
Coaquette A
,
Vuoto F
,
Faure K
,
Mahlaoui N
,
Kotnik P
,
Battelino T
,
Trebušak Podkrajšek K
,
Kisand K
,
Ferré EMN
,
DiMaggio T
,
Rosen LB
,
Burbelo PD
,
McIntyre M
,
Kann NY
,
Shcherbina A
,
Pavlova M
,
Kolodkina A
,
Holland SM
,
Zhang SY
,
Crow YJ
,
Notarangelo LD
,
Su HC
,
Abel L
,
Anderson MS
,
Jouanguy E
, et al. Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1. J Exp Med. 2021 07 05; 218(7).
PMID:
33890986
.
Citations:
22
Fields:
All
Allergy and Immunology
Med
Medicine (General)
Translation:
Humans
Vazquez SE
,
Bastard P
,
Kelly K
,
Gervais A
,
Norris PJ
,
Dumont LJ
,
Casanova JL
,
Anderson MS
,
DeRisi JL
. Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma. J Clin Immunol. 2021 08; 41(6):1169-1171.
PMID:
34009544
.
Citations:
8
Fields:
All
Allergy and Immunology
Translation:
Humans
Whitman JD
,
Hiatt J
,
Mowery CT
,
Shy BR
,
Yu R
,
Yamamoto TN
,
Rathore U
,
Goldgof GM
,
Whitty C
,
Woo JM
,
Gallman AE
,
Miller TE
,
Levine AG
,
Nguyen DN
,
Bapat SP
,
Balcerek J
,
Bylsma SA
,
Lyons AM
,
Li S
,
Wong AW
,
Gillis-Buck EM
,
Steinhart ZB
,
Lee Y
,
Apathy R
,
Lipke MJ
,
Smith JA
,
Zheng T
,
Boothby IC
,
Isaza E
,
Chan J
,
Acenas DD
,
Lee J
,
Macrae TA
,
Kyaw TS
,
Wu D
,
Ng DL
,
Gu W
,
York VA
,
Eskandarian HA
,
Callaway PC
,
Warrier L
,
Moreno ME
,
Levan J
,
Torres L
,
Farrington LA
,
Loudermilk RP
,
Koshal K
,
Zorn KC
,
Garcia-Beltran WF
,
Yang D
,
Astudillo MG
,
Bernstein BE
,
Gelfand JA
,
Ryan ET
,
Charles RC
,
Iafrate AJ
,
Lennerz JK
,
Miller S
,
Chiu CY
,
Stramer SL
, et al. Evaluation of SARS-CoV-2 serology assays reveals a range of test performance. Nat Biotechnol. 2020 10; 38(10):1174-1183.
PMID:
32855547
.
Citations:
90
Fields:
Bio
Biotechnology
Translation:
Humans
Cells
PH
Public Health
Start with:
newest
oldest
Include:
line numbers
double spacing
all authors
publication IDs